Filing Details

Accession Number:
0001193805-24-001348
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-13 20:16:26
Reporting Period:
2024-11-11
Accepted Time:
2024-11-13 20:16:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1671858 Ars Pharmaceuticals Inc. SPRY () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1009258 Deerfield Management Company, L.p. (Series C) 345 Park Avenue South, 12Th Floor
New York NY 10010
No No Yes No
1352546 E James Flynn 345 Park Avenue South, 12Th Floor
New York NY 10010
No No Yes No
1603333 Deerfield Private Design Fund Iii, L.p. 345 Park Avenue South, 12Th Floor
New York NY 10010
No No Yes No
1610540 Deerfield Mgmt Iii, L.p. 345 Park Avenue South, 12Th Floor
New York NY 10010
No No Yes No
1680307 Deerfield Private Design Fund Iv, L.p. 345 Park Avenue South, 12Th Floor
New York NY 10010
No No Yes No
1713467 Deerfield Mgmt Iv, L.p. 345 Park Avenue South, 12Th Floor
New York NY 10010
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2024-11-11 40,596 $17.45 5,498,368 No 4 S Indirect Through Deerfield Private Design Fund III, L.P.
Class A Common Stock Disposition 2024-11-11 40,596 $17.45 5,498,367 No 4 S Indirect Through Deerfield Private Design Fund IV, L.P.
Class A Common Stock Disposition 2024-11-11 223,632 $18.15 5,274,736 No 4 S Indirect Through Deerfield Private Design Fund III, L.P.
Class A Common Stock Disposition 2024-11-11 223,632 $18.15 5,274,735 No 4 S Indirect Through Deerfield Private Design Fund IV, L.P.
Class A Common Stock Disposition 2024-11-12 7,853 $17.16 5,266,883 No 4 S Indirect Through Deerfield Private Design Fund III, L.P.
Class A Common Stock Disposition 2024-11-12 7,854 $17.16 5,266,881 No 4 S Indirect Through Deerfield Private Design Fund IV, L.P.
Class A Common Stock Disposition 2024-11-12 9,554 $17.77 5,257,329 No 4 S Indirect Through Deerfield Private Design Fund III, L.P.
Class A Common Stock Disposition 2024-11-12 9,553 $17.77 5,257,328 No 4 S Indirect Through Deerfield Private Design Fund IV, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Through Deerfield Private Design Fund III, L.P.
No 4 S Indirect Through Deerfield Private Design Fund IV, L.P.
No 4 S Indirect Through Deerfield Private Design Fund III, L.P.
No 4 S Indirect Through Deerfield Private Design Fund IV, L.P.
No 4 S Indirect Through Deerfield Private Design Fund III, L.P.
No 4 S Indirect Through Deerfield Private Design Fund IV, L.P.
No 4 S Indirect Through Deerfield Private Design Fund III, L.P.
No 4 S Indirect Through Deerfield Private Design Fund IV, L.P.
Footnotes
  1. The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.90 to $17.90, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 4, 5 and 6 of this Form 4.
  2. This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (collectively with Fund III, the "Funds"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P. and Deerfield Management Company, L.P.
  3. In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
  4. The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.91 to $18.51, inclusive.
  5. The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.68 to $17.65, inclusive.
  6. The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.69 to $17.82, inclusive.